# CORRESP — Coherus Oncology, Inc.  (CHRS)  (CIK 0001512762)

> <strong>Coherus Oncology, Inc.  (CHRS)  (CIK 0001512762) → SEC staff</strong> · filed 2025-12-05 · ticker CHRS · SIC 2836

## What is this

A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.

## Key facts

- **Accession number:** 0001104659-25-118941
- **Form:** CORRESP
- **Filer:** Coherus Oncology, Inc.  (CHRS)  (CIK 0001512762)
- **CIK:** 0001512762
- **Ticker:** CHRS
- **Filed:** 2025-12-05
- **SIC industry:** 2836
- **HQ:** Redwood City, CA

## Primary source

PDF letter: https://www.sec.gov/Archives/edgar/data/1512762/000110465925118941/filename1.htm

EDGAR review history for this filer: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1512762&type=UPLOAD&dateb=&owner=include&count=40

## Citation

> US Securities and Exchange Commission, EDGAR CORRESP comment letter, Coherus Oncology, Inc.  (CHRS)  (CIK 0001512762) (CIK 0001512762), filed 2025-12-05, accession 0001104659-25-118941. Retrieved via MORVS 2026-11-03 from https://api.morvs.ai/comment-letter/0001104659-25-118941.

---

*[SEC comment letters dataset](/datasets/sec-comment-letters) · CC0 1.0*